Respiratory and cardiovascular effects of COVID-19 infection and their management

Area of Science:

• Infectious Diseases
• Virology
• Public Health

Background:

• The COVID-19 pandemic, caused by SARS-CoV-2, presents a significant global health and economic challenge.
• SARS-CoV-2 is a highly infectious novel RNA coronavirus that primarily affects the respiratory tract but can cause systemic disease.
• The virus targets organs with high angiotensin-converting enzyme-2 (ACE2) expression, including the lungs, small intestine, and vascular endothelium.

Purpose of the Study:

• To describe the clinical manifestations and pathological impact of SARS-CoV-2 infection.
• To highlight the multiorgan damage caused by the virus, particularly in the lungs and cardiovascular system.
• To emphasize the importance of phenotype-based ventilation strategies and personal protection for healthcare workers.

Main Methods:

• Review of clinical data and pathological findings associated with SARS-CoV-2 infection.
• Analysis of organ systems affected by the virus, focusing on ACE2 expression.
• Discussion of current treatment approaches, including oxygen supplementation and mechanical ventilation.

Main Results:

• COVID-19 presents as mild disease in 81% of cases, with severe disease in the remainder.
• The virus causes multiorgan damage, with the lungs being the most affected, followed by the cardiovascular system.
• Severe hypoxia necessitates mechanical ventilation, with strategies guided by patient phenotype.

Conclusions:

• SARS-CoV-2 infection can lead to severe, multiorgan disease, necessitating careful patient management.
• Tailored ventilation strategies based on distinct COVID-19 phenotypes are crucial for patient outcomes.
• Strict adherence to personal protection protocols is essential to prevent healthcare worker infection and nosocomial spread.